Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Celltrion Inc (068270 KS)
Watchlist
721
Analysis
Health Care
•
South Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Samsung Life Insurance
•
08 Jun 2026 14:38
KODEX Top 5 Plus Rebalance This Friday Final Outcome Shifted on Late May Volatility
KODEX Top 5 Plus rebalance this Friday saw the final print shift after late May price volatility drove a change in the screening outcome.
Sanghyun Park
Follow
188 Views
Share
bearish
•
Quantitative Analysis
•
07 Jun 2026 10:20
KRX Foreign Holding Weekly (Jun 5th): Samsung Electronics, SK Hynix, LG Electronics, NAVER
We analyzed KRX foreign holding data for the past week and highlighted foreign holding changes in Samsung Electronics, SK Hynix, LG Electronics,...
Ke Yan, CFA, FRM
Follow
131 Views
Share
bearish
•
Thematic (Sector/Industry)
•
28 Aug 2019 13:51
The Week That Was @ Smartkarma in Korea, Japan, China/HK: Megvii, GSOMIA, Cho Kuk, & Sony
On August 22nd, the South Korean government announced that it has decided to terminate the GSOMIA (General Security of Military Information...
Douglas Kim
Follow
658 Views
Share
bullish
•
SK Biopharmaceuticals
•
02 Jun 2026 08:30
SK Biopharmaceuticals (326030 KS): Record High Operating Profit in 1Q; Xcopri Guidance Maintained
SK Biopharmaceuticals reported strong 1Q26 results with revenue up 58% YoY, operating profit at all-time high, and guided for Xcopri U.S. revenue...
Tina Banerjee
Follow
126 Views
Share
bullish
•
Thematic (Sector/Industry)
•
13 May 2019 17:58
Smartkarma’s Week that Was in JP/KR: Chiyoda, SoftBank, Nexon and CJ Olive Networks
We have covered two weeks of insights in this week’s report as we did not publish the weekly during the first week of May as Japan was enjoying an...
Shifara Samsudeen, FCMA, CGMA
Follow
629 Views
Share
First
Previous
20
21
22
23
24
25
26
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x